Nádia M. Grilo

Monitoring abacavir bioactivation in humans: screening for an aldehyde metabolite.

N. Grilo, A. Antunes, U. Caixas, 2013, Toxicology letters.

Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients.

N. Grilo, A. Antunes, U. Caixas, 2016, Toxicology letters.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms

J. Serpa, N. Grilo, A. Antunes, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Evidence for nevirapine bioactivation in man: searching for the first step in the mechanism of nevirapine toxicity.

N. Grilo, A. Antunes, U. Caixas, 2012, Toxicology.

Long-term maraviroc use as salvage therapy in HIV-2 infection.

N. Grilo, U. Caixas, A. Marinho, 2012, The Journal of antimicrobial chemotherapy.

Bioactivation to an aldehyde metabolite--possible role in the onset of toxicity induced by the anti-HIV drug abacavir.

N. Grilo, A. Antunes, C. Charneira, 2014, Toxicology letters.